9813158|t|Alzheimer's disease-linked mutation of presenilin 2 (N141I-PS2) drastically lowers APPalpha secretion: control by the proteasome.
9813158|a|Most of early onset familial forms of Alzheimer's disease (FAD) are due to inherited mutations located on two homologous proteins, presenilins 1 and 2 (PS1 and PS2) encoded by chromosomes 14 and 1, respectively. Here we show that the expression of wild type (wt)-PS2 in human HEK293 cells increases the production of the physiological alpha-secretase-derived product, APPalpha. By contrast, APPalpha secretion is drastically reduced in cells expressing the FAD-linked N141I-PS2. We establish that wt-PS2, N141I-PS2 and their C-terminal maturation fragment are degraded by the enzymatic multicatalytic complex, proteasome. Interestingly, two selective proteasome inhibitors, Z-IE(Ot-Bu)A-Leucinal and lactacystin potentiate the APPalpha secretion observed in wtPS2-expressing cells and further amplify the N141I-PS2-induced decrease in APPalpha production. By contrast, a series of pharmacological agents unable to affect the proteasome do not modify PS2 immunoreactivities and APPalpha recoveries. Altogether, our data indicate that: 1) wtPS2 positively modulates the alpha-secretase physiological pathway of betaAPP maturation in human cells; 2) N141I mutation on PS2 drastically lowers the secretion of APPalpha; 3) Proteasome inhibitors prevent the degradation of wtPS2, N141I-PS2 and their C-terminal maturation product. This protection against proteasomal degradation directly modulates the APPalpha secretion response elicited by wt- and FAD-linked PS2 expression in human HEK293 cells.
9813158	0	19	Alzheimer's disease	Disease	MESH:D000544
9813158	39	51	presenilin 2	Gene	5664
9813158	53	58	N141I	ProteinMutation	tmVar:p|SUB|N|141|I;HGVS:p.N141I;VariantGroup:0;CorrespondingGene:5664;RS#:63750215;CorrespondingSpecies:9606;CA#:224953
9813158	59	62	PS2	Gene	5664
9813158	168	187	Alzheimer's disease	Disease	MESH:D000544
9813158	189	192	FAD	Gene	5663
9813158	261	280	presenilins 1 and 2	Gene	5663;5664
9813158	282	285	PS1	Gene	5663
9813158	290	293	PS2	Gene	5664
9813158	393	396	PS2	Gene	5664
9813158	400	405	human	Species	9606
9813158	406	412	HEK293	CellLine	CVCL:0045
9813158	587	590	FAD	Gene	5663
9813158	598	603	N141I	ProteinMutation	tmVar:p|SUB|N|141|I;HGVS:p.N141I;VariantGroup:0;CorrespondingGene:5664;RS#:63750215;CorrespondingSpecies:9606;CA#:224953
9813158	604	607	PS2	Gene	5664
9813158	630	633	PS2	Gene	5664
9813158	635	640	N141I	ProteinMutation	tmVar:p|SUB|N|141|I;HGVS:p.N141I;VariantGroup:0;CorrespondingGene:5664;RS#:63750215;CorrespondingSpecies:9606;CA#:224953
9813158	641	644	PS2	Gene	5664
9813158	804	825	Z-IE(Ot-Bu)A-Leucinal	Chemical	-
9813158	830	841	lactacystin	Chemical	MESH:C067713
9813158	935	940	N141I	ProteinMutation	tmVar:p|SUB|N|141|I;HGVS:p.N141I;VariantGroup:0;CorrespondingGene:5664;RS#:63750215;CorrespondingSpecies:9606;CA#:224953
9813158	941	944	PS2	Gene	5664
9813158	1080	1083	PS2	Gene	5664
9813158	1261	1266	human	Species	9606
9813158	1277	1282	N141I	ProteinMutation	tmVar:p|SUB|N|141|I;HGVS:p.N141I;VariantGroup:0;CorrespondingGene:5664;RS#:63750215;CorrespondingSpecies:9606;CA#:224953
9813158	1295	1298	PS2	Gene	5664
9813158	1404	1409	N141I	ProteinMutation	tmVar:p|SUB|N|141|I;HGVS:p.N141I;VariantGroup:0;CorrespondingGene:5664;RS#:63750215;CorrespondingSpecies:9606;CA#:224953
9813158	1410	1413	PS2	Gene	5664
9813158	1574	1577	FAD	Gene	5663
9813158	1585	1588	PS2	Gene	5664
9813158	1603	1608	human	Species	9606
9813158	1609	1615	HEK293	CellLine	CVCL:0045
9813158	Association	MESH:D000544	RS#:63750215;HGVS:p.N141I;CorrespondingGene:5664
9813158	Association	MESH:C067713	RS#:63750215;HGVS:p.N141I;CorrespondingGene:5664
9813158	Positive_Correlation	MESH:D000544	5663
9813158	Negative_Correlation	MESH:C067713	5664
9813158	Association	MESH:D000544	5664
9813158	Association	5663	5664
9813158	Association	MESH:D000544	5664

